These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Effects of experimental recombinant interferons on multiple sclerosis. Johnson KP; Panitch HS Trans Am Clin Climatol Assoc; 1989; 100():171-6. PubMed ID: 2479162 [No Abstract] [Full Text] [Related]
50. [Interferons in the treatment of solid tumors. A general review]. Dorval T; Pouillart P Bull Cancer; 1988; 75(9):885-8. PubMed ID: 2462946 [TBL] [Abstract][Full Text] [Related]
51. Modulation of interferons inhibitory effect on cell growth by the mitogenic stimulus. Taylor-Papadimitriou J; Rozengurt E Tex Rep Biol Med; 1981-1982; 41():509-16. PubMed ID: 6189216 [No Abstract] [Full Text] [Related]
52. Pharmacokinetics of interferons. A reappraisal. Bocci V Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823 [No Abstract] [Full Text] [Related]
53. [Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]. Shimoyama M; Yamada H; Kitahara T; Adachi I; Yoshida S; Okazaki N; Tobinai K; Konda C; Kakizoe T; Matsumoto K; Ise T; Ichikawa H Gan No Rinsho; 1983 May; 29(6):589-97. PubMed ID: 6192265 [TBL] [Abstract][Full Text] [Related]
54. [Medical and commercial aspects of human interferon]. von Eichborn JF Arzneimittelforschung; 1986 Feb; 36(2):279-82. PubMed ID: 2421742 [TBL] [Abstract][Full Text] [Related]